Impact of antigen specificity on CD4+T cell activation in chronic HIV-1 infection

BMC Infectious Diseases

Table 1 Donor profiles

Donor ID	Gender	Age	HIV status	RNA copies/ml	CD4 cells/ul	CD4 (%)
02RB	M	56	positive	160000	326	21
09GH	F	41	positive	64000	339	25
12VF	M	38	positive	39000	398	17
13OJ	M	42	positive	33000	426	31
19CT	M	46	positive	140000	323	29
21JH	M	40	positive	6800	293	28
23RB	M	24	positive	110000	598	37
24BZ	F	27	positive	34000	341	27
26PC	M	40	positive	37000	440	35
27BS	F	49	positive	26000	262	21
28JA	M	58	positive	24000	650	25
31PO	M	46	positive	130000	472	22
34GB	M	28	positive	8100	482	25
35DS	M	48	positive	6600	578	33
40TF	M	53	positive	11000	793	27
05KC	M	43	positive	35200	257	21
06MV	F	58	positive	73000	596	27
11CS	F	42	positive	19000	362	23
20YB	M	47	positive	16200	722	30
	M 74%	Mean 43				Mean 27
	F 26%	SD 10				SD 5
HD01	F	32	negative			56
HD03	M	28	negative			39
HD05	F	29	negative			36
HD09	F	31	negative			48
HD11	F	27	negative			31
HD12	M	45	negative			39
HD13	M	59	negative			39
HD14	F	53	negative			48
HD15	F	52	negative			50
HD16	F	55	negative			54
	M 30%	Mean 41				Mean 44
	F 70%	SD 13				SD 8

Demographics, HIV status and CD4 profiles of study participants. M = male, F = female, SD = standard deviation.

ISSN: 1471-2334